Low genetic barrier to nucleoside analogue resistance in HIV-2

被引：0
|
作者：
Smith, R. A. [1 ]
Anderson, D. J. [1 ]
Pyrak, C. L. [1 ]
Kiviat, N. B. [1 ]
Gottlieb, G. S. [1 ]
Preston, B. D. [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
ANTIVIRAL THERAPY | 2007年 / 12卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S137 / S137
页数：1
相关论文
共 50 条
  • [1] Low genetic barrier to nucleoside analogue resistance in HIV-2
    Smith, R. A.
    Anderson, D. J.
    Pyrak, C. L.
    Kiviat, N. B.
    Gottlieb, G. S.
    Preston, B. D.
    [J]. ANTIVIRAL THERAPY, 2007, 12 : S137 - S137
  • [2] Antiretroviral Drug Resistance in HIV-2: Three Amino Acid Changes Are Sufficient for Classwide Nucleoside Analogue Resistance
    Smith, Robert A.
    Anderson, Donovan J.
    Pyrak, Crystal L.
    Preston, Bradley D.
    Gottlieb, Geoffrey S.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (09): : 1323 - 1326
  • [3] Amino acid residues in HIV-2 reverse transcriptase that restrict the development of nucleoside analogue resistance through the excision pathway
    Alvarez, Mar
    Nevot, Maria
    Mendieta, Jesus
    Martinez, Miguel A.
    Menendez-Arias, Luis
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (07) : 2247 - 2259
  • [4] HIV-1 and HIV-2 Reverse Transcriptases: Different Mechanisms of Resistance to Nucleoside Reverse Transcriptase Inhibitors
    Boyer, Paul L.
    Clark, Patrick K.
    Hughes, Stephen H.
    [J]. JOURNAL OF VIROLOGY, 2012, 86 (10) : 5885 - 5894
  • [5] Analysis of HIV-2 RT mutants provides evidence that resistance of HIV-1 RT and HIV-2 RT to nucleoside analogs involves a repositioning of the template-primer
    Perach, M
    Rubinek, T
    Hughes, SH
    Hizi, A
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1997, 268 (03) : 648 - 654
  • [6] GENETIC AND BIOLOGICAL VARIATION OF HIV-2
    GAO, F
    YUE, L
    BIGGAR, RJ
    NEEQUAYE, AE
    HO, DD
    SHARP, PM
    SHAW, GM
    HAHN, BH
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S107 - S107
  • [7] GENETIC AND BIOLOGICAL VARIATION OF HIV-2
    GAO, F
    YUE, L
    BIGGAR, RJ
    NEEQUAYE, AE
    HO, DD
    SHARP, PM
    SHAW, GM
    HAHN, BH
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 9 - 9
  • [8] Natural resistance of HIV-2 to zidovudine
    Reid, P
    MacInnes, H
    Cong, M
    Heneine, W
    García-Lerma, JG
    [J]. ANTIVIRAL THERAPY, 2004, 9 (04) : U41 - U41
  • [9] HIV-2 antiretroviral drug resistance and genetic diversity in Cote d'Ivoire: presence of key resistance mutations in HIV-2 naive patients from Abidjan
    Toni, T. A.
    Yapo, V.
    Asahchop, E.
    Mbamy, M.
    Daligou, M.
    Chenal, H.
    Masquelier, B.
    [J]. ANTIVIRAL THERAPY, 2010, 15 : A150 - A150
  • [10] Mechanisms of nucleoside analogue resistance
    Boyer, PL
    Sarafianos, SG
    Arnold, E
    Hughes, SH
    [J]. ANTIVIRAL THERAPY, 2002, 7 : S32 - S32
12345